Position in ABBV
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$938,868
+$145,465 QoQ
Shares Held
3,731
+2.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.94%
of 13F equity value
Holder Rank
#2,598
of 4,153 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Traveka Wealth, LLC holds $7,683,360 across 9 Drug Manufacturers - General names. ABBV ranks #3 (12.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,362 | $2,833,053 | |
| 2 | JNJ |
Johnson & Johnson
|
6,397 | $1,624,646 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
3,731 | $938,868 | |
| 4 | AZN |
Astrazeneca PLC
|
3,416 | $647,741 | |
| 5 | NVS |
Novartis AG
|
3,165 | $496,018 | |
| 6 | MRK |
Merck & Co., Inc.
|
2,711 | $348,363 | |
| 7 | AMGN |
Amgen Inc
|
926 | $335,323 | |
| 8 | NVO |
Novo Nordisk A S
|
5,265 | $252,404 |
All Filings in ABBV
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $938,868 | 3,731 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $793,403 | 3,648 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $827,362 | 3,621 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $942,367 | 4,070 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $741,366 | 3,994 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $822,994 | 3,928 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $693,918 | 3,905 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $441,762 | 2,237 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $369,454 | 2,154 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $379,496 | 2,084 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $613,526 | 3,959 | Shares | Sole | 2024-01-24 | |
| No filing history on record for this holder in this stock. | ||||||